BRAF and melanoma: Moreover, BRAF/PTEN-mutated mouse models have also allowed the study of the molecular mechanisms underlying melanoma, namely the role of the Activating Molecule in Beclin-1-Regulated Autophagy in the development of this cancer [251], as well as the identification of new therapeutic targets, such as sirtuin 5 [252].